G vs. MRK
Compare and contrast key facts about Genpact Limited (G) and Merck & Co., Inc. (MRK).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: G or MRK.
Correlation
The correlation between G and MRK is 0.30, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
G vs. MRK - Performance Comparison
Key characteristics
G:
0.81
MRK:
-0.22
G:
1.66
MRK:
-0.17
G:
1.20
MRK:
0.98
G:
0.54
MRK:
-0.17
G:
3.09
MRK:
-0.40
G:
7.25%
MRK:
11.88%
G:
27.61%
MRK:
21.07%
G:
-64.14%
MRK:
-68.62%
G:
-18.23%
MRK:
-24.95%
Fundamentals
G:
$7.63B
MRK:
$253.12B
G:
$3.64
MRK:
$4.78
G:
11.89
MRK:
20.93
G:
1.70
MRK:
0.07
G:
$4.66B
MRK:
$63.22B
G:
$1.63B
MRK:
$47.97B
G:
$820.26M
MRK:
$20.41B
Returns By Period
In the year-to-date period, G achieves a 23.20% return, which is significantly higher than MRK's -7.33% return. Both investments have delivered pretty close results over the past 10 years, with G having a 9.32% annualized return and MRK not far behind at 8.92%.
G
23.20%
-5.54%
36.49%
23.38%
1.06%
9.32%
MRK
-7.33%
2.66%
-22.03%
-5.13%
5.59%
8.92%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
G vs. MRK - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Genpact Limited (G) and Merck & Co., Inc. (MRK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
G vs. MRK - Dividend Comparison
G's dividend yield for the trailing twelve months is around 1.45%, less than MRK's 3.17% yield.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
G Genpact Limited | 1.45% | 1.59% | 1.08% | 0.81% | 0.95% | 0.81% | 1.11% | 0.76% | 0.00% | 0.00% | 0.00% | 0.00% |
MRK Merck & Co., Inc. | 3.17% | 2.72% | 2.52% | 3.41% | 3.03% | 2.48% | 2.60% | 3.36% | 3.14% | 3.43% | 3.12% | 3.46% |
Drawdowns
G vs. MRK - Drawdown Comparison
The maximum G drawdown since its inception was -64.14%, smaller than the maximum MRK drawdown of -68.62%. Use the drawdown chart below to compare losses from any high point for G and MRK. For additional features, visit the drawdowns tool.
Volatility
G vs. MRK - Volatility Comparison
The current volatility for Genpact Limited (G) is 5.30%, while Merck & Co., Inc. (MRK) has a volatility of 6.43%. This indicates that G experiences smaller price fluctuations and is considered to be less risky than MRK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
G vs. MRK - Financials Comparison
This section allows you to compare key financial metrics between Genpact Limited and Merck & Co., Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities